OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+35.52%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$376M
AUM Growth
+$376M
(+22%)
Cap. Flow
+$4M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
62.6%
Holding
53
New
13
Increased
11
Reduced
14
Closed
8
Top Buys
| 1 |
Arvinas
ARVN
|
$10.9M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
$6.33M |
| 3 |
Codexis
CDXS
|
$5.88M |
| 4 |
TG Therapeutics
TGTX
|
$5.55M |
| 5 |
Relmada Therapeutics
RLMD
|
$3.51M |
Top Sells
| 1 |
MOR
MorphoSys AG American Depositary Shares
MOR
|
$10.5M |
| 2 |
Biohaven
BHVN
|
$10.2M |
| 3 |
TELA Bio
TELA
|
$6M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$4.29M |
| 5 |
Geron
GERN
|
$4.06M |
Sector Composition
| 1 | Healthcare | 97.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Biodesix
BDSX
$61.9M
| $3.61M | 0.96% |
496,500
+40,927
| +9% | +$298K |
|
27
Trevi Therapeutics
TRVI
$871M
| $3.4M | 0.9% |
2,535,000
+829,100
| +49% | +$1.11M |
|
28
Jasper Therapeutics
JSPR
$44.2M
| $3.14M | 0.84% |
+3,985,340
| New | +$3.14M |
|
29
Intellia Therapeutics
NTLA
$1.26B
| $3.02M | 0.8% |
+99,000
| New | +$3.02M |
|
30
NewAmsterdam Pharma
NAMS
$2.8B
| $2.96M | 0.79% |
+265,388
| New | +$2.96M |
|
31
Larimar Therapeutics
LRMR
$337M
| $2.84M | 0.75% |
623,500
-225,000
| -27% | -$1.02M |
|
32
Ventyx Biosciences
VTYX
$184M
| $2.82M | 0.75% |
+1,140,000
| New | +$2.82M |
|
|
SYRS
33
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $2.8M | 0.74% |
+359,370
| New | +$2.8M |
|
34
Gossamer Bio
GOSS
$587M
| $2.72M | 0.72% |
2,982,200
-1,772,000
| -37% | -$1.62M |
|
35
Protagonist Therapeutics
PTGX
$3.62B
| $2.58M | 0.69% |
+112,700
| New | +$2.58M |
|
|
36
KalVista Pharmaceuticals
KALV
$713M
| $1.84M | 0.49% |
150,000
-350,000
| -70% | -$4.29M |
|
37
Verastem
VSTM
$585M
| $1.72M | 0.46% |
211,400
| – | – |
|
|
NYXH
38
Nyxoah
NYXH
$220M
| $1.6M | 0.43% |
344,800
-97,096
| -22% | -$451K |
|
|
MOR
39
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $1.44M | 0.38% |
145,000
-1,064,380
| -88% | -$10.5M |
|
40
Precigen
PGEN
$1.42B
| $1.36M | 0.36% |
1,012,500
+84,000
| +9% | +$113K |
|
41
Sutro Biopharma
STRO
$85.6M
| $1.29M | 0.34% |
+301,491
| New | +$1.29M |
|
42
Context Therapeutics
CNTX
$75.6M
| $1.1M | 0.29% |
+975,000
| New | +$1.1M |
|
43
Fulcrum Therapeutics
FULC
$353M
| $878K | 0.23% |
+130,000
| New | +$878K |
|
44
Aligos Therapeutics
ALGS
$75.1M
| $861K | 0.23% |
+1,297,000
| New | +$861K |
|
45
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $640K | 0.17% |
+37,500
| New | +$640K |
|
|
TCON
46
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| – | – |
-4,764,508
| Closed | -$848K |
|
47
Xeris Biopharma Holdings
XERS
$1.27B
| – | – |
-390,000
| Closed | -$725K |
|
|
48
TELA Bio
TELA
$65.4M
| – | – |
-750,000
| Closed | -$6M |
|
49
Kezar Life Sciences
KZR
$28.5M
| – | – |
-425,000
| Closed | -$506K |
|
|
IGMS
50
DELISTED
IGM Biosciences
IGMS
| – | – |
-261,000
| Closed | -$2.18M |
|